Long-lasting HIV injection is a step closer after second GSK study

Long-lasting HIV injection is a step closer after second GSK study


A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for some patients to be filed with regulators. The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога